Role of the autonomic nervous system in modulating cardiac arrhythmias

Circulation Research

Volumn 114, Issue 6, 2014, Pages 1004-1021

  Shen, Mark J ^a   Zipes, Douglas P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; autonomic nervous system; ventricular fibrillation

Indexed keywords

AUTONOMIC INNERVATION; AUTONOMIC NERVE; AUTONOMIC NERVOUS SYSTEM; BRUGADA SYNDROME; CHOLINERGIC SYSTEM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; NERVE STIMULATION; NEUROMODULATION; PRIORITY JOURNAL; REVIEW;

ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM; VENTRICULAR FIBRILLATION;

ACUPUNCTURE THERAPY; ANIMALS; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR AGENTS; CATHETER ABLATION; CRYOSURGERY; DEATH, SUDDEN, CARDIAC; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION THERAPY; GANGLIA, AUTONOMIC; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MEDULLA OBLONGATA; MODELS, CARDIOVASCULAR; MODELS, NEUROLOGICAL; SPINAL CORD; VAGUS NERVE; VAGUS NERVE STIMULATION; VENTRICULAR FIBRILLATION;

EID: 84897831871     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.302549     Document Type: Review

References (203)

1. Harvey W. Exercitatio Anatomica de Motu Cordis et Sanguinis in Animalibus. Springfeld, IL: Charles C Thomas; 1929.
2. Levy MN, Manuel NG, Martin P, Zieske H. Sympathetic and para-sympathetic interactions upon the left ventricle of the dog. Circ.Res. 1966;19:5-10
3. Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ Res. 1971;29:437-445.
4. Martins JB, Zipes DP. Effects of sympathetic and vagal nerves on recovery properties of the endocardium and epicardium of the canine left ventricle. Circ Res. 1980;46:100-110.
5. Yuan BX, Ardell JL, Hopkins DA, Losier AM, Armour JA. Gross and microscopic anatomy of the canine intrinsic cardiac nervous system. Anat Rec. 1994;239:75-87.
6. Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247:289-298.
7. Leriche R, Herman L, Fontaine R. Ligature de la coronaire gauche et fonc-tion du coeur après énervation sympathique. C R Soc Biol 1931;107:547
8. McEachern CG. Manning GW HG. Sudden occlusion of coronary arteries following removal of cardiosensory pathways: experimental study. Arch Intern Med. 1940;65:661-670.
9. Harris AS, Estandia A, Tillotson RF. Ventricular ectopic rhythms and ventricular fbrillation following cardiac sympathectomy and coronary occlusion. Am J Physiol. 1951;165:505-512.
10. Kapa S, Venkatachalam KL, Asirvatham SJ. The autonomic nervous system in cardiac electrophysiology: an elegant interaction and emerging concepts. Cardiol Rev. 2010;18:275-284.
11. Taggart P, Critchley H, Lambiase PD. Heart-brain interactions in cardiac arrhythmia. Heart. 2011;97:698-708.
12. Shen MJ, Choi EK, Tan AY, Lin SF, Fishbein MC, Chen LS, Chen PS. Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol. 2012;9:30-39.
13. Schwartz PJ. Cutting nerves and saving lives. Heart Rhythm. 2009;6:760-763.
14. Armour JA. Functional anatomy of intrathoracic neurons innervating the atria and ventricles. Heart Rhythm. 2010;7:994-996.
15. Kawashima T. The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution. Anat Embryol (Berl). 2005;209:425-438.
16. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes. The third fat pad. Circulation. 1997;95:2573-2584.
17. Pauza DH, Skripka V, Pauziene N, Stropus R. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259:353-382.
18. Pauza DH, Skripka V, Pauziene N. Morphology of the intrinsic cardiac nervous system in the dog: a whole-mount study employing his-tochemical staining with acetylcholinesterase. Cells Tissues Organs. 2002;172:297-320.
19. Hou Y, Scherlag BJ, Lin J, Zhang Y, Lu Z, Truong K, Patterson E, Lazzara R, Jackman WM, Po SS. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fbrillation. J Am Coll Cardiol. 2007;50:61-68.
20. Tan AY, Li H, Wachsmann-Hogiu S, Chen LS, Chen PS, Fishbein MC. Autonomic innervation and segmental muscular disconnections at the human pulmonary vein-atrial junction: implications for catheter ablation of atrial-pulmonary vein junction. J Am Coll Cardiol. 2006;48:132-143.
21. Rubart M, Zipes DP. Mechanisms of sudden cardiac death. J Clin Invest. 2005;115:2305-2315.
22. Rosenblueth A, Simeone FA. The interrelations of vagal and accelerator effects on the cardiac rate. Am J Physiol. 1934;110:42-55.
23. Samaan A. The antagonistic cardiac nerves and heart rate. J Physiol. 1935;83:332-340.
24. Stramba-Badiale M, Vanoli E, De Ferrari GM, Cerati D, Foreman RD, Schwartz PJ. Sympathetic-parasympathetic interaction and accentuated antagonism in conscious dogs. Am J Physiol. 1991;260:H335-H340.
25. Vanhoutte PM, Levy MN. Prejunctional cholinergic modulation of ad-renergic neurotransmission in the cardiovascular system. Am J Physiol. 1980;238:H275-H281.
26. Takahashi N, Zipes DP. Vagal modulation of adrenergic effects on canine sinus and atrioventricular nodes. Am J Physiol. 1983;244:H775-H781.
27. Levy MN, Zieske H. Effect of enhanced contractility on the left ventricular response to vagus nerve stimulation in dogs. Circ Res. 1969;24:303-311.
28. Brack KE, Coote JH, Ng GA. Interaction between direct sympathetic and vagus nerve stimulation on heart rate in the isolated rabbit heart. Exp Physiol. 2004;89:128-139.
29. Schwartz PJ, Pagani M, Lombardi F, Malliani A, Brown AM. A cardiocar-diac sympathovagal refex in the cat. Circ Res. 1973;32:215-220.
30. Shen MJ, Shinohara T, Park HW, et al. Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines. Circulation. 2011;123:2204-2212.
31. Dukes ID, Vaughan Williams EM. Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart. J Physiol. 1984;355:523-546.
32. Lukas A, Antzelevitch C. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation. 1993;88:2903-2915.
33. Shimizu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation. 1998;98:2314-2322.
34. Ng GA, Brack KE, Coote JH. Effects of direct sympathetic and vagus nerve stimulation on the physiology of the whole heart-a novel model of isolated Langendorff perfused rabbit heart with intact dual autonomic in-nervation. Exp Physiol. 2001;86:319-329.
35. Zipes DP, Mihalick MJ, Robbins GT. Effects of selective vagal and stellate ganglion stimulation of atrial refractoriness. Cardiovasc Res. 1974;8:647-655.
36. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fbrillation begets atrial fbrillation. A study in awake chronically instrumented goats. Circulation. 1995;92:1954-1968.
37. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fbrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation. 1998;98:2202-2209.
38. Burashnikov A, Antzelevitch C. Reinduction of atrial fbrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation. 2003;107:2355-2360.
39. Zipes DP, Rubart M. Neural modulation of cardiac arrhythmias and sudden cardiac death. Heart Rhythm. 2006;3:108-113.
40. Goldstein DS. Neuroscience and heart-brain medicine: the year in review. Cleve Clin J Med. 2010;77(suppl 3):S34-S39.
41. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Barorefex sensitivity, clinical correlates, and cardiovascular mortality among patients with a frst myocardial infarction. A prospective study. Circulation. 1988;78:816-824.
42. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Barorefex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Refexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478-484.
43. Elvan A, Wylie K, Zipes DP. Pacing-induced chronic atrial fbrillation impairs sinus node function in dogs. Electrophysiological remodeling. Circulation. 1996;94:2953-2960.
44. Gomes JA, Kang PS, Matheson M, Gough WB Jr, El-Sherif N. Coexistence of sick sinus rhythm and atrial futter-fbrillation. Circulation. 1981;63:80-86.
45. Piccirillo G, Ogawa M, Song J, Chong VJ, Joung B, Han S, Magrì D, Chen LS, Lin SF, Chen PS. Power spectral analysis of heart rate variability and autonomic nervous system activity measured directly in healthy dogs and dogs with tachycardia-induced heart failure. Heart Rhythm. 2009;6:546-552.
46. Jung BC, Dave AS, Tan AY, Gholmieh G, Zhou S, Wang DC, Akingba AG, Fishbein GA, Montemagno C, Lin SF, Chen LS, Chen PS. Circadian variations of stellate ganglion nerve activity in ambulatory dogs. Heart Rhythm. 2006;3:78-85.
47. Ogawa M, Tan AY, Song J, Kobayashi K, Fishbein MC, Lin SF, Chen LS, Chen PS. Cryoablation of stellate ganglia and atrial arrhythmia in ambulatory dogs with pacing-induced heart failure. Heart Rhythm. 2009;6:1772-1779.
48. Tan AY, Zhou S, Ogawa M, Song J, Chu M, Li H, Fishbein MC, Lin SF, Chen LS, Chen PS. Neural mechanisms of paroxysmal atrial fbrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation. 2008;118:916-925.
49. Zhou S, Jung BC, Tan AY, Trang VQ, Gholmieh G, Han SW, Lin SF, Fishbein MC, Chen PS, Chen LS. Spontaneous stellate ganglion nerve activity and ventricular arrhythmia in a canine model of sudden death. Heart Rhythm. 2008;5:131-139.
50. Choi EK, Shen MJ, Han S, Kim D, Hwang S, Sayfo S, Piccirillo G, Frick K, Fishbein MC, Hwang C, Lin SF, Chen PS. Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs. Circulation. 2010;121:2615-2623.
51. Shen MJ, Choi EK, Tan AY, Han S, Shinohara T, Maruyama M, Chen LS, Shen C, Hwang C, Lin SF, Chen PS. Patterns of baseline autonomic nerve activity and the development of pacing-induced sustained atrial fbrilla-tion. Heart Rhythm. 2011;8:583-589.
52. Benjamin EJ, Chen PS, Bild DE, et al. Prevention of atrial fbrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009;119:606-618.
53. Coumel P, Attuel P, Lavallée J, Flammang D, Leclercq JF, Slama R. [The atrial arrhythmia syndrome of vagal origin]. Arch Mal Coeur Vaiss. 1978;71:645-656.
54. Amar D, Zhang H, Miodownik S, Kadish AH. Competing autonomic mechanisms precede the onset of postoperative atrial fbrillation. J Am Coll Cardiol. 2003;42:1262-1268.
55. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fbrillation. Circulation. 2002;105:2753-2759.
56. Tomita T, Takei M, Saikawa Y, Hanaoka T, Uchikawa S, Tsutsui H, Aruga M, Miyashita T, Yazaki Y, Imamura H, Kinoshita O, Owa M, Kubo K. Role of autonomic tone in the initiation and termination of paroxysmal atrial fbrillation in patients without structural heart disease. J Cardiovasc Electrophysiol. 2003;14:559-564.
57. Ogawa M, Zhou S, Tan AY, Song J, Gholmieh G, Fishbein MC, Luo H, Siegel RJ, Karagueuzian HS, Chen LS, Lin SF, Chen PS. Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure. J Am Coll Cardiol. 2007;50:335-343.
58. Patterson E, Lazzara R, Szabo B, Liu H, Tang D, Li YH, Scherlag BJ, Po SS. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol. 2006;47: 1196-1206.
59. Patterson E, Jackman WM, Beckman KJ, Lazzara R, Lockwood D, Scherlag BJ, Wu R, Po S. Spontaneous pulmonary vein fring in man: relationship to tachycardia-pause early afterdepolarizations and triggered arrhythmia in canine pulmonary veins in vitro. J Cardiovasc Electrophysiol. 2007;18:1067-1075.
60. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198-205.
61. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Métayer P, Clémenty J. Spontaneous initiation of atrial fbrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666.
62. Lo LW, Scherlag BJ, Chang HY, Lin YJ, Chen SA, Po SS. Paradoxical long-term proarrhythmic effects after ablating the "head station" gan-glionated plexi of the vagal innervation to the heart. Heart Rhythm. 2013;10:751-757.
63. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.
64. Yanowitz F, Preston JB, Abildskov JA. Functional distribution of right and left stellate innervation to the ventricles. Production of neurogenic electro-cardiographic changes by unilateral alteration of sympathetic tone. Circ Res. 1966;18:416-428.
65. Opthof T, Misier AR, Coronel R, Vermeulen JT, Verberne HJ, Frank RG, Moulijn AC, van Capelle FJ, Janse MJ. Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation. Circ Res. 1991;68:1204-1215.
66. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res. 2004;95:754-763.
67. Barber MJ, Mueller TM, Henry DP, Felten SY, Zipes DP. Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation. 1983;67:787-796.
68. Cao JM, Chen LS, KenKnight BH, Ohara T, Lee MH, Tsai J, Lai WW, Karagueuzian HS, Wolf PL, Fishbein MC, Chen PS. Nerve sprouting and sudden cardiac death. Circ Res. 2000;86:816-821.
69. Chen PS, Chen LS, Cao JM, Sharif B, Karagueuzian HS, Fishbein MC. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res. 2001;50:409-416.
70. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ, Czer L, Wolf PL, Denton TA, Shintaku IP, Chen PS, Chen LS. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation. 2000;101:1960-1969.
71. Swissa M, Zhou S, Gonzalez-Gomez I, Chang CM, Lai AC, Cates AW, Fishbein MC, Karagueuzian HS, Chen PS, Chen LS. Long-term sub-threshold electrical stimulation of the left stellate ganglion and a canine model of sudden cardiac death. J Am Coll Cardiol. 2004;43:858-864.
72. Zhou S, Chen LS, Miyauchi Y, Miyauchi M, Kar S, Kangavari S, Fishbein MC, Sharif B, Chen PS. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ Res. 2004;95:76-83.
73. Han S, Kobayashi K, Joung B, Piccirillo G, Maruyama M, Vinters HV, March K, Lin SF, Shen C, Fishbein MC, Chen PS, Chen LS. Electroanatomic remodeling of the left stellate ganglion after myocardial infarction. J Am Coll Cardiol. 2012;59:954-961.
74. Liu YB, Wu CC, Lu LS, Su MJ, Lin CW, Lin SF, Chen LS, Fishbein MC, Chen PS, Lee YT. Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fbrillation in hypercholesterolemic rabbits. Circ Res. 2003;92:1145-1152.
75. Shusterman V, Aysin B, Gottipaty V, Weiss R, Brode S, Schwartzman D, Anderson KP. Autonomic nervous system activity and the spontaneous initiation of ventricular tachycardia. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring Trial. J Am Coll Cardiol. 1998;32:1891-1899.
76. Cerrone M, Cummings S, Alansari T, Priori SG. A clinical approach to inherited arrhythmias. Circ Cardiovasc Genet. 2012;5:581-590.
77. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and car-diomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308-1339.
78. Verrier RL, Antzelevitch C. Autonomic aspects of arrhythmogenesis: the enduring and the new. Curr Opin Cardiol. 2004;19:2-11.
79. Han J, Moe GK. Nonuniform recovery of excitability in ventricular muscle. Circ Res. 1964;14:44-60.
80. Zipes DP. The long qt syndrome. A rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation. 1991;84:1414-1419.
81. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent M, Garson Jr A, Robinson JL, Benhorin J, Choi S. The long qt syndrome. Prospective longitudinal study of 328 families. Circulation. 1991;84:1136-1144.
82. El-Sherif N, Caref EB, Yin H, Restivo M. The electrophysiological mechanism of ventricular arrhythmias in the long qt syndrome: tri-dimensional mapping of activation and recovery patterns. Circ Res. 1996;79:474-492.
83. Antzelevitch C, Sun ZQ, Zhang ZQ, Yan GX. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. J Am Coll Cardiol. 1996;28:1836-1848.
84. Huffaker R, Lamp ST, Weiss JN, Kogan B. Intracellular calcium cycling, early afterdepolarizations, and reentry in simulated long QT syndrome. Heart Rhythm. 2004;1:441-448.
85. Noda T, Takaki H, Kurita T, et al. Gene-specifc response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J. 2002;23:975-983.
86. Antzelevitch C. Sympathetic modulation of the long QT syndrome. Eur Heart J. 2002;23:1246-1252.
87. Brugada P, Brugada J. Right bundle branch block, persistent st segment elevation and sudden cardiac death: a distinct clinical and electrocardio- graphic syndrome. J Am Coll Cardiol. 1992;20:1391-1396.
88. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, Corrado D, Hauer RN, Kass RS, Nademanee K, Priori SG, Towbin JA; Study Group on the Molecular Basis of Arrhythmias of the European Society of Cardiology. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation. 2002;106:2514-2519.
89. Takigawa M, Noda T, Shimizu W, Miyamoto K, Okamura H, Satomi K, Suyama K, Aihara N, Kamakura S, Kurita T. Seasonal and circadian distributions of ventricular fbrillation in patients with Brugada syndrome. Heart Rhythm. 2008;5:1523-1527.
90. Matsuo K, Kurita T, Inagaki M, Kakishita M, Aihara N, Shimizu W, Taguchi A, Suyama K, Kamakura S, Shimomura K. The circadian pattern of the development of ventricular fbrillation in patients with Brugada syndrome. Eur Heart J. 1999;20:465-470.
91. Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, Shoda M, Toyoshima Y, Hosoda S. Idiopathic ventricular fbrillation induced with vagal activity in patients without obvious heart disease. Circulation. 1997;95:2277-2285.
92. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol. 1996;27:1061-1070.
93. Morita H, Zipes DP, Fukushima-Kusano K, Nagase S, Nakamura K, Morita ST, Ohe T, Wu J. Repolarization heterogeneity in the right ventricular outfow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model. Heart Rhythm. 2008;5:725-733.
94. Morita H, Zipes DP, Morita ST, Lopshire JC, Wu J. Epicardial ablation eliminates ventricular arrhythmias in an experimental model of Brugada syndrome. Heart Rhythm. 2009;6:665-671.
95. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, Likittanasombat K, Bhuripanyo K, Ngarmukos T. Prevention of ventricular fbrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outfow tract epicardium. Circulation. 2011;123:1270-1279.
96. Morita H, Kusano KF, Miura D, Nagase S, Nakamura K, Morita ST, Ohe T, Zipes DP, Wu J. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation. 2008;118:1697-1704.
97. Haïssaguerre M, Derval N, Sacher F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008;358:2016-2023.
98. Rosso R, Kogan E, Belhassen B, Rozovski U, Scheinman MM, Zeltser D, Halkin A, Steinvil A, Heller K, Glikson M, Katz A, Viskin S. J-point elevation in survivors of primary ventricular fbrillation and matched control subjects: incidence and clinical signifcance. J Am Coll Cardiol. 2008;52:1231-1238.
99. Shinohara T, Takahashi N, Saikawa T, Yoshimatsu H. Characterization of J wave in a patient with idiopathic ventricular fbrillation. Heart Rhythm. 2006;3:1082-1084.
100. Yan GX, Lankipalli RS, Burke JF, Musco S, Kowey PR. Ventricular repo-larization components on the electrocardiogram: cellular basis and clinical signifcance. J Am Coll Cardiol. 2003;42:401-409.
101. Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation. 1996;93:372-379.
102. Antzelevitch C, Yan GX. J wave syndromes. Heart Rhythm. 2010;7:549-558.
103. Nam GB, Ko KH, Kim J, Park KM, Rhee KS, Choi KJ, Kim YH, Antzelevitch C. Mode of onset of ventricular fbrillation in patients with early repolarization pattern vs. Brugada syndrome. Eur Heart J. 2010;31:330-339.
104. Abe A, Ikeda T, Tsukada T, Ishiguro H, Miwa Y, Miyakoshi M, Mera H, Yusu S, Yoshino H. Circadian variation of late potentials in idiopathic ventricular fbrillation associated with J waves: insights into alternative pathophysiology and risk stratifcation. Heart Rhythm. 2010;7:675-682.
105. Rosso R, Adler A, Halkin A, Viskin S. Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective. Heart Rhythm. 2011;8:923-929.
106. Mizumaki K, Nishida K, Iwamoto J, Nakatani Y, Yamaguchi Y, Sakamoto T, Tsuneda T, Kataoka N, Inoue H. Vagal activity modulates spontaneous augmentation of J-wave elevation in patients with idiopathic ventricular fbrillation. Heart Rhythm. 2012;9:249-255.
107. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512-1519.
108. Bai R, Napolitano C, Bloise R, Monteforte N, Priori SG. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ Arrhythm Electrophysiol. 2009;2:6-15.
109. Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation. 2004;109:3208-3214.
110. Knollmann BC, Chopra N, Hlaing T, Akin B, Yang T, Ettensohn K, Knollmann BE, Horton KD, Weissman NJ, Holinstat I, Zhang W, Roden DM, Jones LR, Franzini-Armstrong C, Pfeifer K. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest. 2006;116:2510-2520.
111. Cerrone M, Noujaim SF, Tolkacheva EG, Talkachou A, O'Connell R, Berenfeld O, Anumonwo J, Pandit SV, Vikstrom K, Napolitano C, Priori SG, Jalife J. Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2007;101:1039-1048.
112. Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T, Ferrandi C, Koolbergen DR, Odero A, Schwartz PJ. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med. 2008;358:2024-2029.
113. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007;4:675-678.
114. Watanabe H, van der Werf C, Roses-Noguer F, et al. Effects of fe-cainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2013;10:542-547.
115. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988;318:129-133.
116. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Effcacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation. 1992;86:29-37.
117. Wichter T, Schäfers M, Rhodes CG, Borggrefe M, Lerch H, Lammertsma AA, Hermansen F, Schober O, Breithardt G, Camici PG. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation. 2000;101:1552-1558.
118. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, Macisaac AI, Heidbüchel H, Prior DL. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012;33:998-1006.
119. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, Lellouche N, Knecht S, Wright M, Nault I, Miyazaki S, Scavee C, Clementy J, Haïssaguerre M, Jais P. Catheter ablation for atrial fbrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57:160-166.
120. Bertaglia E, Tondo C, De Simone A, Zoppo F, Mantica M, Turco P, Iuliano A, Forleo G, La Rocca V, Stabile G. Does catheter ablation cure atrial fbrillation? Single-procedure outcome of drug-refractory atrial fbrillation ablation: a 6-year multicentre experience. Europace. 2010;12:181-187.
121. Elvan A, Huang XD, Pressler ML, Zipes DP. Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fbrillation and reduces connexin 43 in dogs. Circulation. 1997;96: 1675-1685.
122. Elvan A, Pride HP, Eble JN, Zipes DP. Radiofrequency catheter ablation of the atria reduces inducibility and duration of atrial fbrillation in dogs. Circulation. 1995;91:2235-2244.
123. Bauer A, Deisenhofer I, Schneider R, Zrenner B, Barthel P, Karch M, Wagenpfeil S, Schmitt C, Schmidt G. Effects of circumferential or seg-mental pulmonary vein ablation for paroxysmal atrial fbrillation on cardiac autonomic function. Heart Rhythm. 2006;3:1428-1435.
124. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alferi O. Pulmonary vein denervation enhances long-term beneft after circumferential ablation for paroxysmal atrial f-brillation. Circulation. 2004;109:327-334.
125. Lemola K, Chartier D, Yeh YH, Dubuc M, Cartier R, Armour A, Ting M, Sakabe M, Shiroshita-Takeshita A, Comtois P, Nattel S. Pulmonary vein region ablation in experimental vagal atrial fbrillation: role of pulmonary veins versus autonomic ganglia. Circulation. 2008;117:470-477.
126. Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, Camm AJ. Rapid pulmonary vein isolation combined with autonomic ganglia modifcation: a randomized study. Heart Rhythm. 2011;8:672-678.
127. Nakagawa H, Scherlag BJ, Wu R, Po S, Lockwood D, Yokoyama K, Herring L, Lazzara R, Jackman WM. Addition of selective ablation of autonomic ganglia to pulmonary vein antrum isolation for treatment of paroxysmal and persistent atrial fbrillation. Circulation. 2006;III-459.
128. Katritsis D, Giazitzoglou E, Sougiannis D, Goumas N, Paxinos G, Camm AJ. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fbrillation. Am J Cardiol. 2008;102:330-334.
129. Scanavacca M, Pisani CF, Hachul D, Lara S, Hardy C, Darrieux F, Trombetta I, Negrão CE, Sosa E. Selective atrial vagal denervation guided by evoked vagal refex to treat patients with paroxysmal atrial fbrilla-tion. Circulation. 2006;114:876-885.
130. Lemery R, Birnie D, Tang AS, Green M, Gollob M. Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fbrillation. Heart Rhythm. 2006;3:387-396.
131. Cummings JE, Gill I, Akhrass R, Dery M, Biblo LA, Quan KJ. Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fbrillation in humans. J Am Coll Cardiol. 2004;43:994-1000.
132. Scherlag BJ, Nakagawa H, Jackman WM, Yamanashi WS, Patterson E, Po S, Lazzara R. Electrical stimulation to identify neural elements on the heart: their role in atrial fbrillation. J Interv Card Electrophysiol. 2005;13(suppl 1):37-42
133. de Vos CB, Nieuwlaat R, Crijns HJ, Camm AJ, LeHeuzey JY, Kirchhof CJ, Capucci A, Breithardt G, Vardas PE, Pisters R, Tieleman RG. Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fbrillation: data from the Euro Heart Survey. Eur Heart J. 2008;29:632-639.
134. Pokushalov E, Romanov A, Shugayev P, Artyomenko S, Shirokova N, Turov A, Katritsis DG. Selective ganglionated plexi ablation for paroxysmal atrial fbrillation. Heart Rhythm. 2009;6:1257-1264.
135. Katritsis DG, Pokushalov E, Romanov A, Giazitzoglou E, Siontis GC, Po SS, Camm AJ, Ioannidis JP. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fbrillation: a randomized clinical trial. J Am Coll Cardiol. 2013;62:2318-2325.
136. Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglio-nectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971;285:903-904.
137. Schwartz PJ, Priori SG, Cerrone M, et al. Left cardiac sympathetic dener-vation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004;109:1826-1833.
138. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
139. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fbrillation in a model for sleep apnea. Hypertension. 2012;60:172-178.
140. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, Laufs U, Neuberger HR, Böhm M. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. Int J Cardiol. 2013;167:2846-2851.
141. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity htn-2 trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
142. Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J, Huang C. Effect of renal sympathetic denervation on the inducibility of atrial fbrillation during rapid atrial pacing. J Interv Card Electrophysiol. 2012;35:119-125.
143. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, Moore JH, Hsu KL, Tseng CD, Liau CS, Tseng YZ. Renin-angiotensin system gene polymorphisms and atrial fbrillation. Circulation. 2004;109:1640-1646.
144. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, Hoppe UC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901-909.
145. Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlöf B. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fbrillation in patients with hypertension. JAMA. 2006;296:1242-1248.
146. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fbrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163-1170.
147. Krum H, Barman N, Schlaich M, et al. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911-917.
148. Carpenter RJ, Dillard J, Zion AS, Gates GJ, Bartels MN, Downey JA, De Meersman RE. The acute effects of acupuncture upon autonomic balance in healthy subjects. Am J Chin Med. 2010;38:839-847.
149. Li P, Pitsillides KF, Rendig SV, Pan HL, Longhurst JC. Reversal of refex-induced myocardial ischemia by median nerve stimulation: a feline model of electroacupuncture. Circulation. 1998;97:1186-1194.
150. Lomuscio A, Belletti S, Battezzati PM, Lombardi F. Effcacy of acupuncture in preventing atrial fbrillation recurrences after electrical cardiover-sion. J Cardiovasc Electrophysiol. 2011;22:241-247.
151. Lombardi F, Belletti S, Battezzati PM, Lomuscio A. Acupuncture for paroxysmal and persistent atrial fbrillation: An effective non-pharmacological tool? World J Cardiol. 2012;4:60-65.
152. Li S, Scherlag BJ, Yu L, Sheng X, Zhang Y, Ali R, Dong Y, Ghias M, Po SS. Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fbrillation. Circ Arrhythm Electrophysiol. 2009;2:645-651.
153. Yu L, Scherlag BJ, Li S, Sheng X, Lu Z, Nakagawa H, Zhang Y, Jackman WM, Lazzara R, Jiang H, Po SS. Low-level vagosympathetic nerve stimulation inhibits atrial fbrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia. J Cardiovasc Electrophysiol. 2011;22:455-463.
154. Viskin S, Golovner M, Malov N, Fish R, Alroy I, Vila Y, Laniado S, Kaplinsky E, Roth A. Circadian variation of symptomatic paroxysmal atrial fbrillation. Data from almost 10 000 episodes. Eur Heart J. 1999;20:1429-1434.
155. Shen MJ, Hao-Che Chang, Park HW, George Akingba A, Chang PC, Zheng Zhang, Lin SF, Shen C, Chen LS, Chen Z, Fishbein MC, Chiamvimonvat N, Chen PS. Low-level vagus nerve stimulation up-regulates small conductance calcium-activated potassium channels in the stellate ganglion. Heart Rhythm. 2013;10:910-915.
156. Adelman JP, Maylie J, Sah P. Small-conductance Ca2+-activated K+ channels: form and function. Annu Rev Physiol. 2012;74:245-269.
157. Olgin JE, Takahashi T, Wilson E, Vereckei A, Steinberg H, Zipes DP. Effects of thoracic spinal cord stimulation on cardiac autonomic regulation of the sinus and atrioventricular nodes. J Cardiovasc Electrophysiol. 2002;13:475-481.
158. Bernstein SA, Wong B, Vasquez C, et al. Spinal cord stimulation protects against atrial fbrillation induced by tachypacing. Heart Rhythm. 2012;9:1426-1433, e1423.
159. Terry R. Vagus nerve stimulation: a proven therapy for treatment of epilepsy strives to improve effcacy and expand applications. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:4631-4634.
160. Andréll P, Yu W, Gersbach P, Gillberg L, Pehrsson K, Hardy I, Ståhle A, Andersen C, Mannheimer C. Long-term effects of spinal cord stimulation on angina symptoms and quality of life in patients with refractory angina pectoris-results from the European Angina Registry Link Study (EARL). Heart. 2010;96:1132-1136.
161. Etzion Y. A stimulating environment for the atrial kick: spinal cord stimulation can inhibit atrial fbrillation. Heart Rhythm. 2012;9:1434-1435.
162. Steinbeck G, Andresen D, Bach P, Haberl R, Oeff M, Hoffmann E, von Leitner ER. A comparison of electrophysiologically guided antiarrhyth-mic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 1992;327:987-992.
163. Antz M, Cappato R, Kuck KH. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia. J Cardiovasc Pharmacol. 1995;26:627-635.
164. Opthof T, Dekker LR, Coronel R, Vermeulen JT, van Capelle FJ, Janse MJ. Interaction of sympathetic and parasympathetic nervous system on ventricular refractoriness assessed by local fbrillation intervals in the canine heart. Cardiovasc Res. 1993;27:753-759.
165. Jonnesco T. Traitement chirurgical de l'angine de poitrine par la résec-tion du sympathique cervico-thoracique. Bull Acad de Med. 1920;84:93.
166. Estes EH Jr, Izlar HL Jr. Recurrent ventricular tachycardia. A case successfully treated by bilateral cardiac sympathectomy. Am J Med. 1961;31:493-497.
167. Zipes DP, Festoff B, Schaal SF, Cox C, Sealy WC, Wallace AG. Treatment of ventricular arrhythmia by permanent atrial pacemaker and cardiac sympathectomy. Ann Intern Med. 1968;68:591-597.
168. Schwartz PJ, Motolese M, Pollavini G, Lotto A, Ruberti U, Trazzi R, Bartorelli C, Zanchetti A, Italian Sudden Death Prevention G. Prevention of sudden cardiac death after a frst myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J Cardiovasc Electrophysiol. 1992;3:2-16.
169. Ajijola OA, Lellouche N, Bourke T, Tung R, Ahn S, Mahajan A, Shivkumar K. Bilateral cardiac sympathetic denervation for the management of electrical storm. J Am Coll Cardiol. 2012;59:91-92.
170. Vaseghi M, Gima J, Kanaan C, Ajijola OA, Marmureanu A, Mahajan A, Shivkumar K. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm. 2014;11:360-366.
171. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Böhm M. Renal sympathetic denervation for treatment of electrical storm: frst-in-man experience. Clin Res Cardiol. 2012;101:63-67.
172. Preminger MW, Bradfeld J, Remo B, Dickfeld T, Gupta A, Moriarty J, Mittal S, Shivkumar K, Steinberg JS. Initial experience with bilateral renal artery denervation for the treatment of vt storm. Heart Rhythm. 2013:PO05-160.
173. Linz D, Wirth K, Ukena C, Mahfoud F, Pöss J, Linz B, Böhm M, Neuberger HR. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs. Heart Rhythm. 2013;10:1525-1530.
174. Coetzee WA, Opie LH. Effects of components of ischemia and metabolic inhibition on delayed afterdepolarizations in guinea pig papillary muscle. Circ Res. 1987;61:157-165.
175. Karagueuzian HS. The "nervous" kidney and ventricular fbrillation: a possible game changer? Heart Rhythm. 2013;10:1531-1532.
176. Einbrodt P. Ueber herzreizung und ihr verhaeltnis zum blutdruck. Akademie der Wissenschaften (Vienna) Sitzungsberichte.1859; 38:345.
177. Myers RW, Pearlman AS, Hyman RM, Goldstein RA, Kent KM, Goldstein RE, Epstein SE. Benefcial effects of vagal stimulation and bradycardia during experimental acute myocardial ischemia. Circulation. 1974;49:943-947.
178. Goldstein RE, Karsh RB, Smith ER, Orlando M, Norman D, Farnham G, Redwood DR, Epstein SE. Infuence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs. Circulation. 1973;47:1180-1190.
179. Vanoli E, De Ferrari GM, Stramba-Badiale M, Hull SS Jr, Foreman RD, Schwartz PJ. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res. 1991;68:1471-1481.
180. Zhang Y, Popovic ZB, Bibevski S, Fakhry I, Sica DA, Van Wagoner DR, Mazgalev TN. Chronic vagus nerve stimulation improves auto-nomic control and attenuates systemic infammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009;2:692-699.
181. Calvillo L, Vanoli E, Andreoli E, Besana A, Omodeo E, Gnecchi M, Zerbi P, Vago G, Busca G, Schwartz PJ. Vagal stimulation, through its nicotinic action, limits infarct size and the infammatory response to myocardial ischemia and reperfusion. J Cardiovasc Pharmacol. 2011;58:500-507.
182. Brack KE, Patel VH, Coote JH, Ng GA. Nitric oxide mediates the vagal protective effect on ventricular fbrillation via effects on action potential duration restitution in the rabbit heart. J Physiol. 2007;583:695-704.
183. Ng GA, Brack KE, Patel VH, Coote JH. Autonomic modulation of electrical restitution, alternans and ventricular fbrillation initiation in the isolated heart. Cardiovasc Res. 2007;73:750-760.
184. Cao JM, Qu Z, Kim YH, Wu TJ, Garfnkel A, Weiss JN, Karagueuzian HS, Chen PS. Spatiotemporal heterogeneity in the induction of ventricular fbrillation by rapid pacing: importance of cardiac restitution properties. Circ Res. 1999;84:1318-1331.
185. Sabbah HN, Ilsar I, Zaretsky A, Rastogi S, Wang M, Gupta RC. Vagus nerve stimulation in experimental heart failure. Heart Fail Rev. 2011;16:171-178.
186. Jongsma HJ, Wilders R. Gap junctions in cardiovascular disease. Circ Res. 2000;86:1193-1197.
187. Shinlapawittayatorn K, Chinda K, Palee S, Surinkaew S, Thunsiri K, Weerateerangkul P, Chattipakorn S, KenKnight BH, Chattipakorn N. Low-amplitude, left vagus nerve stimulation signifcantly attenuates ventricular dysfunction and infarct size through prevention of mitochondrial dysfunction during acute ischemia-reperfusion injury. Heart Rhythm. 2013;10:1700-1707.
188. Schwartz PJ, De Ferrari GM, Sanzo A, Landolina M, Rordorf R, Raineri C, Campana C, Revera M, Ajmone-Marsan N, Tavazzi L, Odero A. Long term vagal stimulation in patients with advanced heart failure: frst experience in man. Eur J Heart Fail. 2008;10:884-891.
189. De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, Gavazzi A, Sanzo A, Dennert R, Kuschyk J, Raspopovic S, Klein H, Swedberg K, Schwartz PJ; CardioFit Multicenter Trial Investigators. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J. 2011;32:847-855.
190. Hauptman PJ, Schwartz PJ, Gold MR, Borggrefe M, Van Veldhuisen DJ, Starling RC, Mann DL. Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. Am Heart J. 2012;163:954-962.e1.
191. Neural Cardiac Therapy for Heart Failure Study. http://clinicaltrials. gov/show/NCT01385176. Accessed February 26, 2014.
192. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA. 2000;283:1295-1302.
193. Issa ZF, Zhou X, Ujhelyi MR, Rosenberger J, Bhakta D, Groh WJ, Miller JM, Zipes D P. Thoracic spinal cord stimulation reduces the risk of isch-emic ventricular arrhythmias in a postinfarction heart failure canine model. Circulation. 2005;111:3217-3220.
194. Lopshire JC, Zhou X, Dusa C, Ueyama T, Rosenberger J, Courtney N, Ujhelyi M, Mullen T, Das M, Zipes DP. Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model. Circulation. 2009;120: 286-294.
195. Garlie JB, Zhou X, Shen MJ, Shelton RS, Malhotra S, Vasu H, Park H-W, Zipes DP, Lin S-F, Chen P-S, Lopshire JC. The increased ambulatory nerve activity and ventricular tachycardia in canine post-infarction heart failure is attenuated by spinal cord stimulation (abstract). Heart Rhythm. 2012:PO3-112.
196. Grimaldi R, de Luca A, Kornet L, Castagno D, Gaita F. Can spinal cord stimulation reduce ventricular arrhythmias? Heart Rhythm. 2012;9:1884-1887.
197. Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Heart Failure (DEFEAT-HF). http://clinicaltrials. Gov/ct2/show/nct01112579?Term=nct01112579&rank=1. Accessed August 10, 2011.
198. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specifc triggers for life-threatening arrhythmias. Circulation. 2001;103:89-95.
199. Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Circulation. 2009;119:2426-2434.
200. Moss AJ, Zareba W, Hall WJ, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616-623.
201. Collura CA, Johnson JN, Moir C, Ackerman MJ. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholamin-ergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm. 2009;6:752-759.
202. Coleman MA, Bos JM, Johnson JN, Owen HJ, Deschamps C, Moir C, Ackerman MJ. Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fbrillation/malignant ventricular arrhythmia syndromes besides congenital long-QT syndrome. Circ Arrhythm Electrophysiol. 2012;5:782-788.
203. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fbrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, defnitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fbrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacifc Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacifc Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9:632-696, e621.